Literature DB >> 34287911

Enhanced slow inactivation contributes to dysfunction of a recurrent SCN2A mutation associated with developmental and epileptic encephalopathy.

Surobhi Ganguly1, Christopher H Thompson1, Alfred L George1.   

Abstract

KEY POINTS: The recurrent SCN2A mutation R853Q is associated with developmental and epileptic encephalopathy with typical onset after the first months of life. Heterologously expressed R853Q channels exhibit an overall loss-of-function as a result of multiple defects in time- and voltage-dependent channel properties. A previously unrecognized enhancement of slow inactivation is conferred by the R853Q mutation and is a major driver of loss-of-function. Enhanced slow inactivation is potentiated in the canonical splice isoform of the channel and this may explain the later onset of symptoms associated with R853Q. ABSTRACT: Mutations in voltage gated sodium (NaV ) channel genes, including SCN2A (encoding NaV 1.2), are associated with diverse neurodevelopmental disorders with or without epilepsy that present clinically with varying severity, age-of-onset and pharmacoresponsiveness. We examined the functional properties of the most recurrent SCN2A mutation (R853Q) to determine whether developmentally-regulated alternative splicing impacts dysfunction severity and to investigate effects of the mutation on slow inactivation. We engineered the R853Q mutation into neonatal and adult NaV 1.2 splice isoforms. Channel constructs were heterologously co-expressed in HEK293T cells with human β1 and β2 subunits. Whole-cell patch clamp recording was used to compare time- and voltage-dependent properties of mutant and wild-type channels. The R853Q mutation exhibits an overall loss-of-function attributed to multiple functional defects including a previously undiscovered enhancement of slow inactivation. The mutation exhibited altered voltage dependence of activation and inactivation, slower recovery from inactivation and decreased channel availability during high-frequency depolarizations. More notable were effects on slow inactivation, including a 10-fold slower rate of recovery from slow inactivation exhibited by mutant channels. The impairments in fast inactivation properties were more severe in the neonatal splice isoform, whereas slow inactivation was more pronounced in the splice isoform of the channel expressed predominantly in later childhood. Enhanced later-onset slow inactivation may be a primary driver of the later onset of neurological features associated with this mutation.
© 2021 The Authors. The Journal of Physiology © 2021 The Physiological Society.

Entities:  

Keywords:  channelopathy; developmental and epileptic encephalopathy; epilepsy; sodium channel

Mesh:

Substances:

Year:  2021        PMID: 34287911      PMCID: PMC8446326          DOI: 10.1113/JP281834

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   6.228


  45 in total

1.  Slow recovery from inactivation regulates the availability of voltage-dependent Na(+) channels in hippocampal granule cells, hilar neurons and basket cells.

Authors:  R K Ellerkmann; V Riazanski; C E Elger; B W Urban; H Beck
Journal:  J Physiol       Date:  2001-04-15       Impact factor: 5.182

Review 2.  Cellular and molecular biology of voltage-gated sodium channels.

Authors:  W A Catterall
Journal:  Physiol Rev       Date:  1992-10       Impact factor: 37.312

3.  Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms of SCN2A epilepsy.

Authors:  Géza Berecki; Katherine B Howell; Yadeesha H Deerasooriya; Maria Roberta Cilio; Megan K Oliva; David Kaplan; Ingrid E Scheffer; Samuel F Berkovic; Steven Petrou
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-29       Impact factor: 11.205

Review 4.  Hippocampal GABAergic Inhibitory Interneurons.

Authors:  Kenneth A Pelkey; Ramesh Chittajallu; Michael T Craig; Ludovic Tricoire; Jason C Wester; Chris J McBain
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

5.  Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.

Authors:  Markus Wolff; Katrine M Johannesen; Ulrike B S Hedrich; Silvia Masnada; Guido Rubboli; Elena Gardella; Gaetan Lesca; Dorothée Ville; Mathieu Milh; Laurent Villard; Alexandra Afenjar; Sandra Chantot-Bastaraud; Cyril Mignot; Caroline Lardennois; Caroline Nava; Niklas Schwarz; Marion Gérard; Laurence Perrin; Diane Doummar; Stéphane Auvin; Maria J Miranda; Maja Hempel; Eva Brilstra; Nine Knoers; Nienke Verbeek; Marjan van Kempen; Kees P Braun; Grazia Mancini; Saskia Biskup; Konstanze Hörtnagel; Miriam Döcker; Thomas Bast; Tobias Loddenkemper; Lily Wong-Kisiel; Friedrich M Baumeister; Walid Fazeli; Pasquale Striano; Robertino Dilena; Elena Fontana; Federico Zara; Gerhard Kurlemann; Joerg Klepper; Jess G Thoene; Daniel H Arndt; Nicolas Deconinck; Thomas Schmitt-Mechelke; Oliver Maier; Hiltrud Muhle; Beverly Wical; Claudio Finetti; Reinhard Brückner; Joachim Pietz; Günther Golla; Dinesh Jillella; Karen M Linnet; Perrine Charles; Ute Moog; Eve Õiglane-Shlik; John F Mantovani; Kristen Park; Marie Deprez; Damien Lederer; Sandrine Mary; Emmanuel Scalais; Laila Selim; Rudy Van Coster; Lieven Lagae; Marina Nikanorova; Helle Hjalgrim; G Christoph Korenke; Marina Trivisano; Nicola Specchio; Berten Ceulemans; Thomas Dorn; Katherine L Helbig; Katia Hardies; Hannah Stamberger; Peter de Jonghe; Sarah Weckhuysen; Johannes R Lemke; Ingeborg Krägeloh-Mann; Ingo Helbig; Gerhard Kluger; Holger Lerche; Rikke S Møller
Journal:  Brain       Date:  2017-05-01       Impact factor: 13.501

6.  De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies.

Authors:  I Ogiwara; K Ito; Y Sawaishi; H Osaka; E Mazaki; I Inoue; M Montal; T Hashikawa; T Shike; T Fujiwara; Y Inoue; M Kaneda; K Yamakawa
Journal:  Neurology       Date:  2009-09-29       Impact factor: 9.910

Review 7.  Sodium channelopathies in neurodevelopmental disorders.

Authors:  Miriam H Meisler; Sophie F Hill; Wenxi Yu
Journal:  Nat Rev Neurosci       Date:  2021-02-02       Impact factor: 34.870

8.  Axonal sodium channel NaV1.2 drives granule cell dendritic GABA release and rapid odor discrimination.

Authors:  Daniel Nunes; Thomas Kuner
Journal:  PLoS Biol       Date:  2018-08-20       Impact factor: 8.029

9.  Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations.

Authors:  Brian J O'Roak; Pelagia Deriziotis; Choli Lee; Laura Vives; Jerrod J Schwartz; Santhosh Girirajan; Emre Karakoc; Alexandra P Mackenzie; Sarah B Ng; Carl Baker; Mark J Rieder; Deborah A Nickerson; Raphael Bernier; Simon E Fisher; Jay Shendure; Evan E Eichler
Journal:  Nat Genet       Date:  2011-05-15       Impact factor: 38.330

10.  Severe deficiency of the voltage-gated sodium channel NaV1.2 elevates neuronal excitability in adult mice.

Authors:  Jingliang Zhang; Xiaoling Chen; Muriel Eaton; Jiaxiang Wu; Zhixiong Ma; Shirong Lai; Anthony Park; Talha S Ahmad; Zhefu Que; Ji Hea Lee; Tiange Xiao; Yuansong Li; Yujia Wang; Maria I Olivero-Acosta; James A Schaber; Krishna Jayant; Chongli Yuan; Zhuo Huang; Nadia A Lanman; William C Skarnes; Yang Yang
Journal:  Cell Rep       Date:  2021-08-03       Impact factor: 9.423

View more
  1 in total

1.  SCN2A-Related Epilepsy: The Phenotypic Spectrum, Treatment and Prognosis.

Authors:  Qi Zeng; Ying Yang; Jing Duan; Xueyang Niu; Yi Chen; Dan Wang; Jing Zhang; Jiaoyang Chen; Xiaoling Yang; Jinliang Li; Zhixian Yang; Yuwu Jiang; Jianxiang Liao; Yuehua Zhang
Journal:  Front Mol Neurosci       Date:  2022-03-30       Impact factor: 5.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.